Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (91-100 of 214) with videos related to

Pageof 22
Sort By:
Chemmedchem|November 8, 2006
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2)Antonio Lavecchia, Roberta Costi, Marino Artico, et al.
The Journal of Biological Chemistry|February 26, 2003
Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activityGiuseppina Blanca, Fausto Baldanti, Stefania Paolucci, et al.
Chemmedchem|November 8, 2006
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1)Roberto Di Santo, Roberta Costi, Marino Artico, et al.
Nucleic Acids Research|August 27, 2024
Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loopsMassimiliano Secchi, Anna Garbelli, Valentina Riva, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complexGiada A Locatelli, Giuseppe Campiani, Reynel Cancio, et al.
Chemmedchem|March 28, 2009
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitorsFederico Falchi, Fabrizio Manetti, Fabio Carraro, et al.
Angewandte Chemie (International Ed. in English)|February 6, 2010
Crystal structure of HIV-1 reverse transcriptase bound to a non-nucleoside inhibitor with a novel mechanism of actionSéverine Freisz, Guillaume Bec, Marco Radi, et al.
Chemmedchem|May 10, 2018
Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine ScaffoldsSuzanne J F Kaptein, Paolo Vincetti, Emmanuele Crespan, et al.
The Journal of Biological Chemistry|October 9, 2002
Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesisGiovanni Maga, Giuseppe Villani, Kristijan Ramadan, et al.
Journal of Medicinal Chemistry|April 25, 2009
Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitorGiuseppe Manfroni, Jan Paeshuyse, Serena Massari, et al.
Pageof 22

Showing results (91-100 of 214) with videos related to

Sort By:
Pageof 22
Chemmedchem|November 8, 2006
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2)Antonio Lavecchia, Roberta Costi, Marino Artico, et al.
The Journal of Biological Chemistry|February 26, 2003
Nevirapine resistance mutation at codon 181 of the HIV-1 reverse transcriptase confers stavudine resistance by increasing nucleotide substrate discrimination and phosphorolytic activityGiuseppina Blanca, Fausto Baldanti, Stefania Paolucci, et al.
Chemmedchem|November 8, 2006
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1)Roberto Di Santo, Roberta Costi, Marino Artico, et al.
Nucleic Acids Research|August 27, 2024
Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loopsMassimiliano Secchi, Anna Garbelli, Valentina Riva, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complexGiada A Locatelli, Giuseppe Campiani, Reynel Cancio, et al.
Chemmedchem|March 28, 2009
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitorsFederico Falchi, Fabrizio Manetti, Fabio Carraro, et al.
Angewandte Chemie (International Ed. in English)|February 6, 2010
Crystal structure of HIV-1 reverse transcriptase bound to a non-nucleoside inhibitor with a novel mechanism of actionSéverine Freisz, Guillaume Bec, Marco Radi, et al.
Chemmedchem|May 10, 2018
Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine ScaffoldsSuzanne J F Kaptein, Paolo Vincetti, Emmanuele Crespan, et al.
The Journal of Biological Chemistry|October 9, 2002
Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesisGiovanni Maga, Giuseppe Villani, Kristijan Ramadan, et al.
Journal of Medicinal Chemistry|April 25, 2009
Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitorGiuseppe Manfroni, Jan Paeshuyse, Serena Massari, et al.
Pageof 22